Latest Posts

22 Apr 2019

AVLS RECEIVING RESEARCH ABSTRACTS FOR 2019 ANNUAL CONGRESS EMERGING SCIENCE PROGRAM

           The American Vein & Lymphatic Society (AVLS) is accepting research abstracts for presentation at the AVLS 2019 Annual Congress. Access to emerging science in the medical field is essential for physicians to deepen clinical competence and improve their practice. The AVLS 2019 Annual Congress Emerging

0
13 Apr 2019

BiosupportMD dietary supplements as adjuncts in venous, lymphatic care*

  BiosupportMD is a nutraceutical company created by John Chuback, MD, FACS, RPVI, RVT, RPhS, and his business partners Christopher Tichio and Alexander von Summer in 2015. The company was the brainchild of Dr. Chuback, a board certified general and cardiovascular surgeon who has been specializing in the treatment of

0
13 Apr 2019

Healogics adds vein ablation to wound care treatments

Healogics, the nation’s largest provider of advanced chronic wound care services, announced in March that they have added vein ablation to their in-house service offerings through a new program called Healogics VeinCare. Healogics CMO William Ennis, DO, MBA, MMM, CPE, said this program allows Healogics to provide patients with a

0
13 Apr 2019

DABRA hits 94% success rate in treating PAD

Ra Medical Systems Inc. announced in early March study results that concluded DABRA Laser System achieved 94 percent success rates in patients with peripheral artery disease. Athar Ansari, MD, director of the California Heart & Vascular Clinic and principal in the study, said DABRA (Destruction of Arteriosclerotic Blockages by laser

0
13 Apr 2019

FDA issues ‘concerning signal’ on paclitaxel-coated devices

The FDA said in late March that its preliminary review of long-term follow-up data found a “potentially concerning signal” of increased long-term mortality in people with peripheral artery disease who were treated with paclitaxel-coated devices compared to those treated with bare devices. In a letter to healthcare providers, the FDA

0
SHARE

Home